MEMORANDUM ORDER

SUE L. ROBINSON, District Judge.

At Wilmington this 30th day of March, 2015, having reviewed defendants' motions to dismiss for lack of subject matter jurisdiction, and the papers filed in connection therewith;

IT IS ORDERED that said motions (Civ. No. 14-779, D.I. 13; Civ. No. 14-1189, D.I. 8) are granted, for the reasons that follow:

1. Background. Plaintiffs NCR Corporation ("NCR") and Nautilus Hyosung America ("NHA") (collectively, "plaintiffs") have filed declaratory judgment actions against defendants Automated Transactions, LLC and Transaction Holding::; Ltd. (collectively, "ATL" or "defendants") in an effort to invalidate 14 of the 28 patents in ATL's patent family portfolio which relate to automated teller machines ("ATMs").1 The above captioned lawsuits were filed at about the same time that ATL moved to dismiss all of its pending infringement cases, which an MDL Order had consolidated before this Court. (Civ. No. 13-MD-2429-SLR).2 There is no dispute that the MDL litigation resulted from ATL's patent enforcement campaign against scores of ATM users, including banks, financial service providers, credit unions, and restaurants. Plaintiffs both manufacture ATMs, and contend that ATL's infringement contentions in the MDL cases were based on the functionality of plaintiffs' ATMs as disclosed in their documents produced in the MDL cases. Both plaintiffs have had customers sued by ATL and, according to NCR, "there are thousands of them in the United States using the same accused ATMs with the same accused functionality." (D.I. 16 at 2) Although "ATL has offered to grant covenants not to sue any NCR customer that has ever received a letter alleging any infringement of ATL's patents NCR alleges is an imminent threat" (Civ. No. 14-779, D.I. 15, ¶ 8), ATL has not offered to NCR itself (or to NHA) covenants not to sue. ATL has attempted to sell the patents-in-suit,3 thus far unsuccessfully, and its managing member (also the named inventor on the patents) has represented that "ATL has no plans to initiate any legal proceedings related to its patent portfolio." (Id. at 116)

2. Standard of review. Under the Supreme Court's controlling decision in Medlmmune, Inc. v. Genentech, Inc., 549 U.S. 118 (2007), the test to be applied by this court in deciding ATL's motions to dismiss is "whether the facts alleged, under all the circumstances, show that there is a substantial controversy, between parties having adverse legal interests, of sufficient immediacy and reality to warrant the issuance of a declaratory judgement." Id. at 127 (citation omitted). The Supreme Court acknowledged that this inquiry will necessarily be fact specific and must be made in consideration of all the relevant circumstances. Consequently, the cases in this area "do not draw the brightest of lines between those declaratory judgment actions that satisfy the case-or-controversy requirement and those that do not." Id.

3. Contentions. Defendants argue that both declaratory judgment complaints should be dismissed pursuant to Fed. R. Cic. P. 12(b)(1) because,

(Civ. No. 14-779, D.I. 14 at 3-4) Plaintiffs counter that "the undisputed and indisputable facts demonstrate a longstanding, unresolved, substantial controversy between ATL and [plaintiffs] concerning the patents-in-suit as applied to [ATMs] manufactured and sold by" plaintiffs. (Id., D.I. 16 at 1)

4. Conclusion. In light of the totality of the circumstances,4 and consistent with the need to preserve scarce judicial resources,5 defendants' motions to dismiss the pending declaratory judgment actions are granted, without prejudice to plaintiffs' renewal of this litigation should defendants (or any other owner of the patents-in-suit) choose to again enforce these patents against NCR, NHA, or any of their customers.